Categories
|
Subjects
|
VHL Instance
|
|
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Non-Melanoma Skin Cancer |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Non-migraine Headache |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Obesity |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r, Oral Health |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Oral Conditions and Disorders |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Other Blood Disorders |
|
VHL, |
Cardiovascular Diseases, Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Cardiovascular Diseases |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Other Hemoglobinopathies and Hemolytic Anaemias |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Other Malignant Neoplasms |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Other Respiratory Diseases |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r, Women's Health |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Ovary Cancer |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Pancreas Cancer |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Parkinson Disease |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Prostate Cancer |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Salt Intake |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Sense Organ Diseases |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Sickle Cell Disorders |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Skin Diseases |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Stomach Cancer; |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Testicular Cancer |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Thalassemia’s |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Thyroid Cancer |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Trachea, Bronchus, Lung Cancers |
|
VHL, |
Chronic and Non Communicable Diseases, SDG 3r |
SDG 3 Target 3.4 Reduce premature mortality due to noncommunicable diseases: Venous Thromboembolic Disease |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Alcohol |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Opioid Abuse |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Cannabis Related Disorders |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Hypnotics, Sedatives or Anxiolytic Related Disorders |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Cocaine and Other Stimulant-Related Disorders |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Hallucinogen Related Disorders |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Inhalant Related Disorders |
|
VHL, |
SDG 3r, Mental Health |
SDG 3 Target 3.5 Prevention and treatment of consumption of psychoactive substances: Other Psychoactive Substance Related Disorders |
|
VHL, |
SDG 3r |
SDG 3 Target 3.6 Reduce deaths and the trauma caused by road accidents: Substance abuse |
|
VHL, |
SDG 3r |
SDG 3 Target 3.6 Reduce deaths and the trauma caused by road accidents: Public policies |
|
VHL, |
SDG 3r |
SDG 3 Target 3.6 Reduce deaths and the trauma caused by road accidents: Post-crash response |
|
VHL, |
Universal Coverage of Health, SDG 3r |
SDG 3 Target 3.7 Universal access to health services related to reproductive and sexual health: Family planning and infertility services |
|
VHL, |
Universal Coverage of Health |
SDG 3 Target 3.7 Universal access to health services related to reproductive and sexual health: Adolescent pregnancy |
|
VHL, |
Universal Coverage of Health, SDG 3r |
SDG 3 Target 3.7 Universal access to health services related to reproductive and sexual health: Safe abortion services |
|
VHL, |
Universal Coverage of Health, Gender, SDG 3r |
SDG 3 Target 3.7 Universal access to health services related to reproductive and sexual health: Violence against women and harmful practices |
|
VHL, |
Universal Coverage of Health, SDG 3r |
SDG 3 Target 3.7 Universal access to health services related to reproductive and sexual health: Sexual health and reproductive rights |
|
VHL, |
Universal Coverage of Health, SDG 3r |
SDG 3 Target 3.7 Universal access to health services related to reproductive and sexual health: Sexually transmitted infections prevention and care |
|
VHL, |
COVID-19, Complementary therapies |
Post-Acute COVID-19 Sequelae |
|
VHL, |
Complementary therapies |
Reduction of Maternal Mortality |
|
VHL, |
Complementary therapies |
Cupping Therapy |
|
VHL, |
Complementary therapies |
Moxibustion |
|
VHL, |
Environmental Health |
Interventions to Reduce Exposure to Household Air Pollution |
|
VHL, |
Complementary therapies |
Malnutrition and Interventions in PHC |
|
VHL, |
Universal Coverage of Health, Sustainable Development Goals |
Strategies to Reduce Health Inequalities |
|
VHL, |
Communicable and Parasitic Diseases |
Clinical Practice Guide and Visceral Leishmaniasis |
|
VHL, |
|
Clinical Practice Guide and Dyslexia |
|
VHL, |
Mental Health |
Clinical Practice Guide and Schizophrenia |
|
VHL, |
Mental Health |
Struggle in the relationship of spouses |
|
VHL, |
Mental Health |
Mental disorders and assessment of health technologies |
|
VHL, |
Women's Health |
Uterine artery embolization as a treatment for leiomyomas |
|
VHL, |
Mental Health |
Risk factors for body dysmorphic disorders |
|
VHL, |
Metodology of Studies in Health, Public Health |
Refuse Disposal and assessment of health technologies |
|
VHL, |
Disaster Preparedness and Response, Mental Health |
Psychology in emergencies and disasters |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Case report |
|
VHL, |
Metodology of Studies in Health |
Systematic Review of Cystic Fibrosis |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Controlled clinical trial |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Diagnostic study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Etiology study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Evaluation studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Clinical practice guide |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Health economic evaluation |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Health technology assessment |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Incidence studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Observational study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Evidence synthesis |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Prevalence studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Prognostic study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Qualitative research |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Randomized controlled trial |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Reviews |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Risk factors |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Screening studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Systematic review/Meta Analysis |
|
VHL, |
Communicable and Parasitic Diseases, Virus Diseases |
Monkeypox: outbreak and control |
|
VHL, |
Communicable and Parasitic Diseases, Virus Diseases |
Monkeypox: Transmission |
|
VHL, |
Communicable and Parasitic Diseases, Virus Diseases |
Monkeypox: Therapeutics |
|
VHL, |
Communicable and Parasitic Diseases, Virus Diseases |
Monkeypox: Diagnosis |
|
VHL, |
Social Determinants of Health, Environmental Health, Sustainable Development Goals |
Agenda 2030. Clean water and sanitation – Goal 6.6 Ecosystems related to water |
|
VHL, |
Social Determinants of Health, Environmental Health, Sustainable Development Goals |
Clean water for sustainable development |
|
VHL, |
Social Determinants of Health, Environmental Health, Sustainable Development Goals |
Sanitation for sustainable development |
|
VHL, |
Social Determinants of Health, Environmental Health, Sustainable Development Goals |
Educational Resources |
|
VHL, |
Social Determinants of Health, Environmental Health, Sustainable Development Goals |
Policy Briefs |
|
VHL, |
Universal Coverage of Health, Sustainable Development Goals, SDG 3r |
ODS3 -Meta3.8: Achieve universal access to health: delivery Arrangements |
|
VHL, |
Universal Coverage of Health, Sustainable Development Goals, SDG 3r |
ODS3 Meta3.8 Achieve universal access to health: governance arrangements |
|
VHL, |
Universal Coverage of Health, Sustainable Development Goals, SDG 3r |
ODS3 Meta3.8: Achieve universal access to health: financial arrangements |
|
VHL, |
Universal Coverage of Health, Sustainable Development Goals, SDG 3r |
ODS3 Meta3.8: Achieve universal access to health: multisectoral coordination |
|
VHL, |
Chronic and Non Communicable Diseases, Gender |
Risk factors and incidence of breast cancer in transsexuals |
|
VHL, |
Disaster Preparedness and Response |
Response capacity in psychological first aid in disaster situations |
|
VHL, |
Indigenous Health |
Alcoholism and vulnerability to the Indian’s health |
|
VHL, |
Mental Health, Health Services |
Rehabilitation of people with disabilities, and work of Psychologists in CER (Center Specialized in Rehabilitation) |
|
VHL, |
Bacterial Infections |
Drug Treatment for Helicobacter pylori (H. Pylori) Infection |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Traditional medicine |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Vaccines |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Long Covid |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Variants |
|
VHL, |
Health Policy |
Social control in the Unified Health System (SUS) |
|
VHL, |
Metodology of Studies in Health |
Clinical Research |
|
VHL, |